FDA aproves GlaxoSmithKline Tetanus, Diptheria, Whooping cough vaccine, Boostrix®, for adults

08.12.08 - 15:27 ... source : GlaxoSmithKline US

... New Indication for Booster Vaccine Expands Disease Protection to Individuals Aged 10-64 Years GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX® [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 19-64 years of age.BOOSTRIX offers protection against tetanus, diphtheria and pertussis (whooping cough) to individuals 10-64 years of age - the broadest age range for any Tdap vaccine. BOOSTRIX was previously approved as a booster vaccine for preteens and teens. "Whooping cough is a highly contagious respiratory disease that can be prevented through vaccination, yet, according to the Centers for Disease Control and Prevention (CDC), most adolescents and adults have not received the recommended booster shot," said Andrew C. Eisenberg MD, MHA, FAAFP, Associate Profess ...» Next (HTML)